Sign in
4

Changes in Ownership

COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001746251-25-000004

EVP & Chief Commercial Officer sold 17,600 shares at an average $48.17 ($847,855)

  • EVP & Chief Commercial Officer acquired 17,600 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dreyer Scott · EVP & Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-08 Exercise or conversion : show line 1 in the form 10b5-1 +17,600 $15.90 $279,840 121,213 D
2025-12-08 Sale : show line 2 in the form 10b5-1 −11,125 $47.89 $532,771 110,088 D
2025-12-08 Sale : show line 3 in the form 10b5-1 −6,475 $48.66 $315,085 103,613 D
Open-market sales · 17,600 sh · avg $48.17 · $847,855

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-08 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Purchase) −17,600 0 D
Loading xslF345X05/form4-12102025_091236.xml…